• This Week’s Articles in PresS Highlights:  Articles on the solution used to culture test-tube embryos and its role in future increased cardiovascular disease risk and the involvement of the Y chromosome in male disease and immune function are featured.
  • This Week’s Articles in PresS Highlights:  New treatments for fibromyalgia and a dairy-derived protein discovered to be a prebiotic that holds promise for treating gastrointestinal conditions and obesity are featured this week.
  • New Research Shows Why Statins Should Be Viewed as a Double-Edged Sword:  Statins have significant cardiovascular benefits, but also serious side effects. A new study finds that statin use impairs stem cell function, which helps in slowing atherosclerosis but hinders other body processes. Because of these effects, the study supports weighing individual risk when considering statins as a preventive measure.
  • Physiological Bioenergetics Meeting Focuses on Power Plant of Cells: The Mitochondria:  The second in the APS fall conference series, this meeting will assemble cross-disciplinary experts who study mitochondrial function and its regulatory mechanisms, with a special emphasis on translational and physiological mechanisms
  • Endothelin-14 Conference to Present Cutting-Edge Therapeutic and Disease Findings:  APS will host the 14th International Conference on Endothelin: Physiology, Pathophysiology and Therapeutics on September 2–5 in Savannah, Ga. The meeting will convene leading global researchers who study endothelin—a type of powerful peptide that constricts blood vessels, raises blood pressure and controls many other cellular functions throughout the body.
  • More...
 
From: 
Email:  
To: 
Email:  
Subject: 
Message:

~/Custom.Templates/Home.aspx